Clarithromycin therapy of experimental Treponema pallidum infections in hamsters.
Clarithromycin was shown to be effective therapy for Treponema pallidum infections in hamsters. Clarithromycin therapy was effective when initiated either 1 or 8 days after infection. The delay in initiation of therapy allowed an active infection to develop. The treponemal burden in lymph tissue of treated hamsters was eradicated, as determined by dark-field microscopy and by inoculation of lymph material into susceptible hamsters. Treatments with clarithromycin and the 14-hydroxy metabolite of clarithromycin were equally effective. Therapy with clarithromycin and penicillin was not antagonistic and did not appear to be synergistic when the two drugs were given concurrently. Pharmacokinetic evaluation of clarithromycin in hamsters showed that the doses which produced effective therapy yielded concentrations in serum similar to those routinely achieved in human sera. These findings demonstrate that clarithromycin is effective in treating active or incubating syphilis in the hamster model and could be useful in treating humans.
Anti-Infective Research Division, Abbott Laboratories, Abbott Park, Illinois 60064-3500.
J
J
Alder
K
K
Jarvis
M
M
Mitten
N L
NL
Shipkowitz
P
P
Gupta
J
J
Clement
D000818:Animals; D017291:Clarithromycin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006224:Cricetinae; D004347:Drug Interactions; D008198:Lymph Nodes / Q000382:microbiology; D008297:Male; D008647:Mesocricetus; D010400:Penicillin G / Q000627:therapeutic use; D013587:Syphilis / Q000188:drug therapy* / Q000382:microbiology; D014210:Treponema pallidum
D017291:Clarithromycin; D010400:Penicillin G